{
    "paper_id": "8f0b773e4e7c87b063a20e452260c97634480e27",
    "metadata": {
        "title": "Journal Pre-proof MANIFESTACIONES CUTANEAS DE LA INFECCION POR COVID 19. A PROPOSITO DE UN CASO",
        "authors": [
            {
                "first": "",
                "middle": [
                    "A"
                ],
                "last": "Manifestaciones Cutaneas De La Infeccion Por Covid 19",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "U",
                "middle": [
                    "N"
                ],
                "last": "Proposito De",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Caso",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "El primer paciente registrado en Espa\u00f1a con coronavirus se conoci\u00f3 el 31 de Enero. Desde entonces, el n\u00famero de contagios ha aumentado progresivamente, rozando ya los 110.000 positivos.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "CUTANEOUS MANIFESTATIONS OF COVID INFECTION 19. ABOUT A CASE"
        },
        {
            "text": "El cuadro cl\u00ednico de COVID-19 se caracteriza por la presencia de s\u00edntomas y signos frecuentes entre los que destacan: fiebre, tos seca o productiva, dolor de garganta, disnea y s\u00edntomas digestivos (diarrea y v\u00f3mitos) 2.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "CUTANEOUS MANIFESTATIONS OF COVID INFECTION 19. ABOUT A CASE"
        },
        {
            "text": "Tambie\u0301n se han descrito otros si\u0301ntomas como ageusia y anosmia 3.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "CUTANEOUS MANIFESTATIONS OF COVID INFECTION 19. ABOUT A CASE"
        },
        {
            "text": "Los resultados de laboratorio a menudo muestran elevaci\u00f3n de la protei\u0301na C reactiva. Las alteraciones en la coagulaci\u00f3n, especialmente del di\u0301mero D y del tiempo de protrombina fueron ma\u0301s frecuentes en pacientes con mayor gravedad4,5. Alrededor de un tercio de los casos presentan datos de citolisis hepa\u0301tica. La linfopenia grave fue el hallazgo hematol\u00f3gico ma\u0301s frecuente en los pacientes cri\u0301ticos4,5",
            "cite_spans": [],
            "ref_spans": [],
            "section": "CUTANEOUS MANIFESTATIONS OF COVID INFECTION 19. ABOUT A CASE"
        },
        {
            "text": "El patr\u00f3n radiol\u00f3gico ma\u0301s frecuente en todas las series fue el infiltrado alveolar 4, 5 J o u r n a l P r e -p r o o f El exudado nasofar\u00edngeo y orofar\u00edngeo, que permite el aislamiento del virus, confirma el diagn\u00f3stico.",
            "cite_spans": [
                {
                    "start": 84,
                    "end": 86,
                    "text": "4,",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 87,
                    "end": 88,
                    "text": "5",
                    "ref_id": "BIBREF1"
                }
            ],
            "ref_spans": [],
            "section": "CUTANEOUS MANIFESTATIONS OF COVID INFECTION 19. ABOUT A CASE"
        },
        {
            "text": "Hay pocos datos sobre las manifestaciones cut\u00e1neas de las personas con COVID-19 6, presentamos un caso de una paciente diagnosticada de infecci\u00f3n por COVID 19 que present\u00f3 manifestaciones cut\u00e1neas despu\u00e9s de la hospitalizaci\u00f3n (a los 5 d\u00edas del alta y 20 d\u00edas despu\u00e9s del inicio de los s\u00edntomas)",
            "cite_spans": [],
            "ref_spans": [],
            "section": "CUTANEOUS MANIFESTATIONS OF COVID INFECTION 19. ABOUT A CASE"
        },
        {
            "text": "Las manifestaci\u00f3n cut\u00e1nea fue una erupci\u00f3n eritematosa. El tronco fue la principal regi\u00f3n involucrada. Se trato de lesiones poco pruriginosas y generalmente las lesiones se curaron en pocos d\u00edas. Aparentemente no hubo ninguna correlaci\u00f3n con la gravedad de la enfermedad, ni con los tratamientos pautados durante el ingreso.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "CUTANEOUS MANIFESTATIONS OF COVID INFECTION 19. ABOUT A CASE"
        },
        {
            "text": "Podemos concluir que las manifestaciones cut\u00e1neas son similares a la afectaci\u00f3n cut\u00e1nea que ocurre durante las infecciones virales comunes. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "CUTANEOUS MANIFESTATIONS OF COVID INFECTION 19. ABOUT A CASE"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Clinical Characteristics of Coronavirus Disease 2019 in China",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "J"
                    ],
                    "last": "-Guan",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "Y"
                    ],
                    "last": "Ni",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMoa2002032"
                ]
            }
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "507--513",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Cutaneous manifestations in COVID-19: a first perspective",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "-Recalcati",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Eur Acad Dermatol Venereol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1111/jdv.16387"
                ]
            }
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Cai L, Cheng ZS et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7:4 BIBLIOGRAF\u00cfA: 1.-Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30;:]. Lancet. 2020;395(10223):497-506 2.-Red Nacional de Vigilancia Epidemiol\u00f3gica.Informe sobre la situaci\u00f3n de COVID-19 en Espan\u0303a [Internet]. Centro Nacional de Epidemiologi\u0301a; 2020 mar. Report No.: 14. Disponible en: https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENA VE/EnfermedadesTransmi sibles/Documents/INFORMES/Informes%20COVID-19/Informe%20n%C2%BA%2014.%20Situaci%C3%B3n%20de%20COVID-19%20en%20Espa%C3%B1a%20a%2024%20marzo%20de%202020.pdf 3.-Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China [published online ahead of print, 2020 Feb 7]. JAMA. 2020;10.1001/jama.2020.1585.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Dr. Juan Carlos Obaya RebollarMANIFESTACIONES CUTANEAS DE LA INFECCION POR COVID 19 A PROPOSITO DE UN CASOEn diciembre de 2019, se describieron casos de neumon\u00eda en Wuhan, China, causado por un nuevo coronavirus llamado coronavirus 2 del s\u00edndrome respiratorio agudo severo (SARS-CoV-2), y la enfermedad resultante se denomin\u00f3 COVID-19 1",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "1.-A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7:4 This article is protected by copyright. All rights reserved This is a first report and a first perspective of SARS-CoV-2 cutaneous manifestations. Indisputably we need more papers to confirm and better understand skin involvement in COVID-19. Additionally, both the awareness of protection and protective facilities, generally lacking in medical departments, are of primary necessity. Transmission of SARS-CoV-2 may occur during an incubation period that may be as long as 14 days 4 . Asymptomatic individuals (or individuals within the incubation period) has also been described as possible carriers, however, the extent to which this occurs remains unknown 5 . Person-to-person spread is thought to occur mainly via respiratory droplets, resembling the spread of influenza. With droplet transmission, virus released in the respiratory secretions when a person with infection coughs, sneezes, or talks can infect another person if it makes direct contact with the mucous membranes; infection can also occur if a person touches an infected surface and then touches his or her eyes, nose, or mouth. Currently, we strongly underline that infection prevention and control are urgent and critical due to the lack of specific treatment and heightened risk of spreading during the incubation period 6 . References ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "annex"
        }
    ]
}